name: Narcolepsy
category: Neurological
parents:
- Sleep Disorder
- Neurological Disease
disease_term:
  preferred_term: narcolepsy
  term:
    id: MONDO:0021107
    label: narcolepsy
has_subtypes:
- name: Narcolepsy Type 1
  description: With cataplexy and orexin/hypocretin deficiency.
- name: Narcolepsy Type 2
  description: Without cataplexy, normal or near-normal orexin levels.
pathophysiology:
- name: Orexin/Hypocretin Deficiency
  description: >
    Loss of orexin-producing neurons in the lateral hypothalamus leads to
    instability of sleep-wake states. Orexin normally promotes and stabilizes
    wakefulness. In Type 1 narcolepsy, >90% of orexin neurons are destroyed,
    likely through autoimmune mechanisms.
  cell_types:
  - preferred_term: Orexin Neuron
    term:
      id: CL:0011109
      label: hypocretin-secreting neuron
  biological_processes:
  - preferred_term: Sleep-Wake Regulation
    term:
      id: GO:0042745
      label: circadian sleep/wake cycle
  evidence:
  - reference: PMID:25728441
    supports: SUPPORT
    snippet: "Narcolepsy with cataplexy is caused by hypocretin deficiency owing to destruction of most of the hypocretin-producing neurons in the hypothalamus."
    explanation: Landmark review establishes hypocretin neuron loss as the cause of narcolepsy with cataplexy.
- name: Autoimmune Destruction
  description: >
    Strong HLA-DQB1*06:02 association suggests autoimmune etiology. T-cell
    mediated destruction of hypocretin neurons is the leading hypothesis.
    Environmental triggers (infections, H1N1 vaccination) may initiate
    the autoimmune response in genetically susceptible individuals.
  biological_processes:
  - preferred_term: Autoimmune Response
    term:
      id: GO:0002460
      label: adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
  evidence:
  - reference: PMID:25728441
    supports: SUPPORT
    snippet: "The hypothesis that a targeted immune-mediated or autoimmune attack causes the specific degeneration of hypocretin neurons arose mainly through the discovery of genetic associations, first with the HLA-DQB1*06:02 allele and then with the T-cell receptor Î± locus."
    explanation: Genetic associations with HLA and TCR loci strongly support autoimmune etiology.
phenotypes:
- name: Excessive Daytime Sleepiness
  category: Sleep
  frequency: OBLIGATE
  diagnostic: true
  notes: Cardinal symptom, irresistible sleep attacks
  phenotype_term:
    preferred_term: Excessive Daytime Sleepiness
    term:
      id: HP:0002329
      label: Drowsiness
- name: Cataplexy
  category: Motor
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Sudden muscle weakness triggered by emotions, pathognomonic for Type 1
  phenotype_term:
    preferred_term: Cataplexy
    term:
      id: HP:0002524
      label: Cataplexy
- name: Sleep Paralysis
  category: Sleep
  frequency: FREQUENT
  notes: Temporary inability to move upon waking or falling asleep
  phenotype_term:
    preferred_term: Sleep Paralysis
    term:
      id: HP:0025233
      label: Sleep paralysis
- name: Hypnagogic Hallucinations
  category: Psychiatric
  frequency: FREQUENT
  notes: Vivid dream-like experiences at sleep onset
  phenotype_term:
    preferred_term: Hypnagogic Hallucination
    term:
      id: HP:0002519
      label: Hypnagogic hallucination
- name: Disrupted Nighttime Sleep
  category: Sleep
  frequency: FREQUENT
  notes: Fragmented nocturnal sleep despite daytime sleepiness
  phenotype_term:
    preferred_term: Sleep Disturbance
    term:
      id: HP:0002360
      label: Sleep disturbance
biochemical:
- name: CSF Orexin/Hypocretin-1
  presence: Decreased
  context: Low or undetectable in Type 1 narcolepsy (<110 pg/mL)
genetic:
- name: HLA-DQB1*06:02
  association: Risk Factor
  notes: Present in >98% of Type 1 narcolepsy, but also 25% of general population
- name: HCRT
  association: Causative
  notes: Rare mutations in hypocretin gene cause familial narcolepsy
- name: HCRTR2
  association: Causative
  notes: Hypocretin receptor 2 mutations (canine model)
environmental:
- name: H1N1 Infection
  notes: Increased risk after 2009 pandemic
- name: Pandemrix Vaccine
  notes: Associated with increased narcolepsy risk in Europe
- name: Streptococcal Infection
  notes: Possible trigger in some cases
treatments:
- name: Sodium Oxybate
  description: First-line for cataplexy and daytime sleepiness, improves nighttime sleep.
  evidence:
  - reference: PMID:22893778
    supports: SUPPORT
    snippet: "Narcolepsy patients on SXB have significant reductions in cataplexy and daytime sleepiness. SXB is well tolerated in patients with narcolepsy, and most adverse events were mild to moderate in severity."
    explanation: Systematic review and meta-analysis of 6 RCTs confirms efficacy for both cataplexy and sleepiness with acceptable safety.
- name: Modafinil
  description: Wake-promoting agent for excessive daytime sleepiness.
- name: Pitolisant
  description: Histamine H3 receptor antagonist, promotes wakefulness.
- name: Solriamfetol
  description: Dopamine/norepinephrine reuptake inhibitor for sleepiness.
- name: Amphetamines
  description: Traditional stimulants (amphetamine, methylphenidate).
- name: Antidepressants
  description: SNRIs/SSRIs for cataplexy (venlafaxine, fluoxetine).
- name: Scheduled Naps
  description: Short planned naps can improve alertness.
datasets:
